I am/have/had
I am looking for
Advanced Filters
Found 283 clinical trials
Multi-center Open-label Phase 1b Study in Patients With Relapsed/Refractory Multiple Myeloma (RRMM)
Primary Objectives: To evaluate the safety and tolerability of isatuximab administered subcutaneously (SC) versus intravenously (IV) To evaluate the pharmacokinetics (PK) of SC and IV isatuximab Secondary Objectives: To estimate absolute bioavailability of SC and IV isatuximab To measure receptor occupancy (RO) after isatuximab SC versus IV administration To assess …
refractory multiple myeloma
arginine hydrochloride
lenalidomide
tuberculosis
corticosteroids
- 0 views
- 04 Dec, 2020
- 13 locations